A Phase I/IIa Trial of Autologous Regulatory T Cell Therapy Together with Donor Bone Marrow Infusion in Kidney Transplantation

被引：0
|
作者：
Oberbauer, R. [1 ]
Muckenhuber, M. [1 ]
Mucha, J. [1 ]
Reindl-Schwaighofer, R. [1 ]
Heinzel, A. [1 ]
Berlakovich, G. [1 ]
Worel, N. [1 ]
Wolzt, M. [1 ]
Lion, T. [1 ]
Edinger, M. [2 ]
Wekerle, T. [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Univ Hosp Regensburg, Regensburg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
540
引用
收藏
页码：S596 / S596
页数：1
相关论文
共 50 条
  • [21] DONOR LEUKOCYTE INFUSION AS THERAPY OF LIFE-THREATENING ADENOVIRAL INFECTIONS AFTER T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION
    HROMAS, R
    CORNETTA, K
    SROUR, E
    BLANKE, C
    BROUN, ER
    BLOOD, 1994, 84 (05) : 1689 - 1690
  • [22] Phase-I trial of combination chemotherapy and donor lymphocyte infusion for relapsed aggressive hematologic malignancies following allogeneic bone marrow transplantation.
    Mookerjee, B
    Couzi, R
    Seber, A
    Miller, C
    Noga, S
    Douglas, T
    Altomonte, V
    Gore, S
    Jones, R
    Vogelsang, G
    Fuchs, E
    BLOOD, 1999, 94 (10) : 162A - 162A
  • [23] Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells
    Zwang, Nicholas A.
    Leventhal, Joseph R.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (07): : 1960 - 1972
  • [24] Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HIA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial
    Mevorach, Dror
    Zuckerman, Tsila
    Reiner, Inna
    Shimoni, Avichai
    Samuel, Simcha
    Nagler, Arnon
    Rowe, Jacob M.
    Or, Reuven
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (01) : 58 - 65
  • [25] Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial
    McGuirk, Joseph P.
    Abhyankar, Sunil H.
    Goswami, Trishna
    Soder, Rupal
    ter Haak, Mariska
    Bruns, Tyce
    Youngblood, Samantha Langford
    Lamb, Lawrence S., Jr.
    BLOOD, 2022, 140 : 7464 - 7465
  • [26] Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients
    Terai, Shuji
    Sakaida, Isao
    HEPATOLOGY RESEARCH, 2008, 38 : S72 - S75
  • [27] Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma
    R Liang
    F Chen
    CK Lee
    YL Kwong
    CS Chim
    CC Yau
    E Chiu
    Bone Marrow Transplantation, 1997, 19 : 91 - 93
  • [28] Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma
    Liang, R
    Chen, F
    Lee, CK
    Kwong, YL
    Chim, CS
    Yau, CC
    Chiu, E
    BONE MARROW TRANSPLANTATION, 1997, 19 (01) : 91 - 93
  • [29] Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
    Mohamadnejad, Mehdi
    Alimoghaddam, Kamran
    Mohyeddin-Bonab, Mandana
    Bagheri, Mohamad
    Bashtar, Maryam
    Ghanaati, Hossein
    Baharvand, Hossein
    Ghavamzadeh, Ardeshir
    Malekzadeh, Reza
    ARCHIVES OF IRANIAN MEDICINE, 2007, 10 (04) : 459 - 466
  • [30] Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke
    Tsang, Kam Sze
    Ng, Chi Ping Stephanie
    Zhu, Xian Lun
    Wong, George Kwok Chu
    Lu, Gang
    Ahuja, Anil Tejbhan
    Wong, Ka Sing Lawrence
    Ng, Ho Keung
    Poon, Wai Sang
    WORLD JOURNAL OF STEM CELLS, 2017, 9 (08): : 133 - 143
12345